Drugs / BCG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01479972 Comparator | Nov 2011 → Nov 2012 | tuberculosis | Serum Life Science Europe GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01479972 ↗ |
| Modality | Vaccine | “commercially available live vaccine BCG” NCT01479972 ↗ |
| Route | Intramuscular | “A total of 48 newborns were vaccinated intradermally with VPM1002 (n = 36) or BCG Danish strain (n = 12) in a phase II open-labeled, randomized trial” PMID 27974398 ↗ Feb 2017 |